Atrás
Rango del Día
$22.00
$22.00
Rango de 52 Semanas
$14.87
$28.06
Volumen
400
Promedio 50D / 200D
$20.56
/
$22.44
Cierre Anterior
$22.00
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.5 | 0.3 |
| P/B | 0.0 | 2.9 |
| ROE % | 2.0 | 3.7 |
| Net Margin % | 1.1 | 3.8 |
| Rev Growth 5Y % | 2.2 | 10.0 |
| D/E | 0.6 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$183.03
$179.43 – $186.18
|
270 B | 1 |
| FY2027 |
$115.41
$113.14 – $117.40
|
260 B | 1 |
| FY2026 |
$116.47
$114.18 – $118.47
|
250 B | 1 |
Puntos Clave
Revenue grew 2.17% annually over 5 years — modest growth
ROE of 1.97% is below average
Generating 11.65B in free cash flow
P/E of 0.45 — trading at a low valuation
Cash machine — converts 421.95% of earnings into free cash flow
Capital efficient — spends only 4.24% of revenue on capex
Crecimiento
Revenue Growth (5Y)
2.17%
Revenue (1Y)2.56%
Earnings (1Y)N/A
FCF Growth (3Y)3.63%
Calidad
Return on Equity
1.97%
ROIC0.88%
Net Margin1.14%
Op. Margin1.09%
Seguridad
Debt / Equity
0.63
Current Ratio1.72
Interest Coverage4.47
Valoración
P/E Ratio
0.45
P/B Ratio0.01
EV/EBITDA17.81
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.56% | Revenue Growth (3Y) | -3.49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -58.03% |
| Revenue Growth (5Y) | 2.17% | Earnings Growth (5Y) | -36.95% |
| Profitability | |||
| Revenue (TTM) | 243.03B | Net Income (TTM) | 2.76B |
| ROE | 1.97% | ROA | 0.99% |
| Gross Margin | 27.65% | Operating Margin | 1.09% |
| Net Margin | 1.14% | Free Cash Flow (TTM) | 11.65B |
| ROIC | 0.88% | FCF Growth (3Y) | 3.63% |
| Safety | |||
| Debt / Equity | 0.63 | Current Ratio | 1.72 |
| Interest Coverage | 4.47 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 0.45 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | -0.34 |
| EV/EBITDA | 17.81 | Dividend Yield | 0.06% |
| Market Cap | 1.25B | Enterprise Value | 47.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 243.03B | 236.95B | 260.91B | 272.94B | 223.02B |
| Net Income | 2.76B | -7.55B | 15.68B | 29.60B | 17.47B |
| EPS (Diluted) | 48.59 | -132.77 | 275.49 | 519.42 | 306.32 |
| Gross Profit | 67.20B | 63.24B | 89.92B | 111.80B | 76.21B |
| Operating Income | 2.64B | -4.04B | 23.38B | 50.49B | 25.39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 279.58B | 290.85B | 297.92B | 286.59B | 252.75B |
| Total Liabilities | 142.29B | 148.34B | 147.88B | 146.41B | 137.45B |
| Shareholders' Equity | 137.11B | 142.51B | 150.05B | 140.18B | 115.31B |
| Total Debt | 86.65B | 81.95B | 77.16B | 73.00B | 80.46B |
| Cash & Equivalents | 40.89B | 39.95B | 44.19B | 46.49B | 42.96B |
| Current Assets | 119.14B | 123.22B | 131.85B | 132.54B | 118.01B |
| Current Liabilities | 69.44B | 64.07B | 64.37B | 70.76B | 62.92B |